Precision Medicine
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights on precision medicine, genomics, targeted therapies, and biomarker strategies for strategic R&D and investment decisions.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Precision Medicine hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
HSA Clinical Trial Modernization: Singapore's New Framework for CITDs
ACT Genomics Expands Cancer Genomic Testing Panel to 101 Genes with 7-Day Turnaround Time
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.